Lnc-GNAQ-6:1 has been shown to be downregulated in gastric cancers and could serve as a potential target marker for GC screening, achieving AUC greater than the standard CEA and CA 72–4 markers (102). This evidence concerns the gene CEACAM5 and gastric cancer.